STACK IMAGE— STACK · 2 COMPOUNDS
GH Peptide Stack
CJC-1295 wo DAC + Tesamorelin
CJC-1295 wo DAC10mg£49.99Tesamorelin15mg£129.99
£179.98
£99.98
SAVE 44%
View stack →
Tesamorelin
PRODUCT IMAGE
HPLC VERIFIED
COA SUPPLIED
≥98.6% PURITY
— Growth
Tesamorelin Growth Hormone Releasing Factor Analogue
For in vitro research use only. Tesamorelin is not for human or veterinary consumption, diagnosis, treatment, or prevention of any condition.
Tesamorelin is a synthetic version of GHRH (Growth Hormone-Releasing Hormone — the signal the brain uses to trigger growth hormone production). Structural modifications have been added to slow how quickly it breaks down in the body, giving it a longer active window. Research has investigated its effects on GH (growth hormone) and IGF-1 (a related signalling protein) levels, and studies have examined its influence on fat distribution around the abdominal area in animal models.
- CAS Number
- 218949-48-9
- Molecular Formula
- C₂₂₁H₃₅₆N₆₄O₆₈S
- HPLC Purity
- 98.6% (batch-verified)
- Form
- Lyophilised powder
- Storage
- 2–8°C, desiccated, protected from light
- Classification
- Research reagent — in vitro use only
Research overview
Tesamorelin is a synthetic analogue — a man-made version with structural modifications — of GHRH (Growth Hormone-Releasing Hormone, the natural signal the brain uses to tell the body to produce growth hormone). The modifications slow its enzymatic breakdown, meaning it remains active in biological systems for longer than the natural version. Research has investigated its effects on GH (growth hormone) and IGF-1 (Insulin-Like Growth Factor 1 — a signalling protein that responds to growth hormone and is involved in cell growth and metabolism) levels. Studies have also examined its effects on visceral fat distribution — how fat is stored around the internal organs in the abdominal area. It is one of the most extensively studied GHRH analogues available in preclinical research. For research use only. Not for human or veterinary consumption.
Summary paraphrased from the peer-reviewed preclinical literature. Full citations will be available in the research library. For in vitro research use only.
Compound specifications
| Common name | Tesamorelin |
|---|---|
| Full name | Growth Hormone Releasing Factor Analogue |
| CAS number | 218949-48-9 |
| Molecular formula | C₂₂₁H₃₅₆N₆₄O₆₈S |
| Molecular weight | 5195.8 g/mol |
| Sequence | trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 |
| HPLC purity | 98.6% (batch-verified) |
| Appearance | White to off-white lyophilised powder |
| Solubility | Bacteriostatic water, sterile saline |
| Storage (lyophilised) | 2–8°C, protected from light |
| Storage (reconstituted) | 2–8°C, up to 28 days |
| Supplied as | 15mg |
Batch testing and certificate of analysis
Every batch of Tesamorelin is third-party HPLC-tested prior to dispatch. A batch-specific certificate of analysis documenting HPLC purity, mass spectrometry confirmation, and appearance is supplied with every order.
Previous batch CoAs are archived in the CoA library. For batch-specific CoA requests prior to purchase, contact veloxpeps@gmail.com.
Stacks containing Tesamorelin
Related compounds
Frequently Asked Research-Use Questions
What purity is Velox Peptides Tesamorelin?
Tesamorelin is supplied at 98.6% HPLC-verified purity. A certificate of analysis is provided with every order. Every batch is third-party tested before dispatch.
How is Tesamorelin supplied and reconstituted for research use?
Tesamorelin is supplied as a lyophilised powder in sterile single-use vials. For in vitro research use, reconstitution is performed with bacteriostatic water. See the reconstitution calculator for volume calculations based on required concentration.
What is Tesamorelin used for in preclinical research?
Tesamorelin is studied in the peer-reviewed literature across the pathways described in the research overview above. Velox Peptides supplies Tesamorelin strictly as a research reagent for in vitro use by qualified researchers. It is not a medicinal product and is not for human or veterinary consumption.
What is the CAS number for Tesamorelin?
The CAS registry number for Tesamorelin is 218949-48-9. This identifier is listed on every batch certificate of analysis supplied with orders.
Compliance notice
For in vitro research use only. Tesamorelin is supplied solely as a research reagent for qualified professionals conducting in vitro or animal-model studies. It is not a medicinal product within the meaning of the Human Medicines Regulations 2012. It has not been evaluated by the MHRA or FDA. It is not intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale.
